Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.69%74.77M | -82.48%10.05M | -60.51%13.16M | -57.58%89.98M | -56.28%74.26M | -55.22%57.32M | 4.86%33.34M | -27.12%212.1M | -22.22%169.85M | -17.39%128M |
| Operating revenue | 0.69%74.77M | -82.48%10.05M | -60.51%13.16M | -57.58%89.98M | -56.28%74.26M | -55.22%57.32M | 4.86%33.34M | -27.12%212.1M | -22.22%169.85M | -17.39%128M |
| Total operating cost | -5.23%116.43M | -36.43%54.52M | -32.99%26.74M | 1.56%178.82M | 1.13%122.86M | -4.49%85.75M | 16.92%39.9M | -7.55%176.07M | -6.34%121.49M | 10.33%89.79M |
| Operating cost | -1.44%64.68M | -63.52%16.46M | -47.94%11.04M | -21.82%104.35M | -28.00%65.63M | -34.34%45.12M | -10.22%21.22M | -8.43%133.48M | -4.98%91.15M | 12.08%68.73M |
| Operating tax surcharges | -42.60%732.36K | -47.42%571.64K | -51.10%163.67K | 13.41%1.75M | 21.59%1.28M | 33.09%1.09M | 24.53%334.67K | 31.62%1.54M | 66.36%1.05M | 90.88%816.86K |
| Operating expense | -4.67%8.86M | 21.36%5.92M | 30.32%2.37M | 109.61%12.23M | 77.61%9.3M | 46.81%4.88M | 35.37%1.82M | 8.21%5.83M | 33.75%5.24M | 88.71%3.32M |
| Administration expense | -1.69%20.94M | -0.11%13.38M | 55.63%6.6M | 60.07%30.42M | 59.10%21.3M | 53.58%13.4M | 12.18%4.24M | -24.42%19M | -33.86%13.39M | -27.48%8.72M |
| Financial expense | 67.20%-2.22M | 72.48%-1.13M | 87.33%-339.25K | 22.43%-7.72M | 15.11%-6.77M | 14.93%-4.11M | -31.80%-2.68M | -36.31%-9.95M | -57.22%-7.97M | -174.43%-4.84M |
| -Interest expense (Financial expense) | -79.84%181.74K | -81.15%123.93K | -75.09%64.67K | 230.83%862.77K | --901.62K | --657.34K | --259.59K | 11,823.71%260.79K | ---- | ---- |
| -Interest Income (Financial expense) | 61.48%-2.43M | 73.46%-1.27M | 87.83%-357.97K | 15.75%-8.62M | 21.16%-6.3M | 1.12%-4.8M | -44.23%-2.94M | -39.28%-10.23M | -56.79%-7.99M | -172.49%-4.85M |
| Research and development | -27.06%23.43M | -23.89%19.32M | -53.90%6.9M | 44.48%37.8M | 72.42%32.12M | 94.77%25.38M | 109.73%14.97M | 29.07%26.16M | 32.47%18.63M | 71.39%13.03M |
| Credit Impairment Loss | -28.00%-17.41M | 72.67%-4.04M | 7.47%-2.08M | 79.76%-3.65M | -30.42%-13.6M | -81.76%-14.78M | -29.37%-2.24M | -96.06%-18.04M | -137.35%-10.43M | -85.10%-8.13M |
| Asset Impairment Loss | ---4.87M | ---4.87M | ---- | -329,321.80%-44.29M | ---- | ---- | ---- | -50.53%13.45K | 90.71%-9.01K | 90.71%-9.01K |
| Other net revenue | ||||||||||
| Invest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.38%2.42K | -99.34%2.42K | -99.20%2.42K |
| Asset deal income | ---- | ---- | ---- | 98.29%-22.76K | ---26.91K | ---52.76K | ---- | ---1.33M | ---- | ---- |
| Other revenue | -68.03%36.62K | -66.71%36.62K | --36.62K | -16.26%34.56K | --114.56K | --110.02K | ---- | -1.25%41.28K | ---- | ---- |
| Operating profit | -2.87%-63.9M | -23.61%-53.34M | -77.27%-15.62M | -918.32%-136.77M | -263.77%-62.11M | -243.49%-43.15M | -116.54%-8.81M | -81.80%16.71M | -55.14%37.93M | -56.66%30.07M |
| Add:Non operating Income | ---- | ---- | ---- | -97.93%113K | -97.98%108K | -99.33%36K | -93.79%111.82K | 79.03%5.47M | 73.08%5.35M | 75.60%5.34M |
| Less:Non operating expense | 1,191.83%12.12M | 611.82%1.7M | 2,352.53%1.23M | 402.65%7.45M | 1,776.31%938.16K | 376.60%238.3K | 0.00%50K | 223.98%1.48M | -50.00%50K | -50.00%50K |
| Total profit | -20.77%-76.02M | -26.95%-55.04M | -92.54%-16.84M | -796.15%-144.11M | -245.60%-62.94M | -222.60%-43.36M | -277.31%-8.75M | -78.08%20.7M | -50.62%43.23M | -51.10%35.36M |
| Less:Income tax cost | -84.90%-3.95M | 18.06%-1.83M | 6.65%-312.32K | -2,017.78%-8.24M | -171.69%-2.14M | -156.16%-2.24M | -186.80%-334.57K | -103.21%-388.87K | -71.00%2.98M | -61.26%3.98M |
| Net profit | -18.52%-72.06M | -29.39%-53.21M | -96.48%-16.53M | -744.26%-135.88M | -251.08%-60.81M | -231.03%-41.12M | -211.15%-8.41M | -74.38%21.09M | -47.90%40.25M | -49.42%31.38M |
| Net profit from continuing operation | -18.52%-72.06M | -29.39%-53.21M | -96.48%-16.53M | -744.26%-135.88M | -251.08%-60.81M | -231.03%-41.12M | -211.15%-8.41M | -74.38%21.09M | -47.90%40.25M | -49.42%31.38M |
| Net profit of parent company owners | -18.52%-72.06M | -29.39%-53.21M | -96.48%-16.53M | -744.26%-135.88M | -251.08%-60.81M | -231.03%-41.12M | -211.15%-8.41M | -74.38%21.09M | -47.90%40.25M | -49.42%31.38M |
| Earning per share | ||||||||||
| Basic earning per share | -18.75%-0.19 | -27.27%-0.14 | -100.00%-0.04 | -716.67%-0.37 | -245.45%-0.16 | -210.00%-0.11 | -100.00%-0.02 | -77.78%0.06 | -47.62%0.11 | -50.00%0.1 |
| Diluted earning per share | -18.75%-0.19 | -27.27%-0.14 | -100.00%-0.04 | -716.67%-0.37 | -245.45%-0.16 | -210.00%-0.11 | -100.00%-0.02 | -77.78%0.06 | -47.62%0.11 | -50.00%0.1 |
| Other composite income | ||||||||||
| Total composite income | -18.52%-72.06M | -29.39%-53.21M | -96.48%-16.53M | -744.26%-135.88M | -251.08%-60.81M | -231.03%-41.12M | -211.15%-8.41M | -74.38%21.09M | -47.90%40.25M | -49.42%31.38M |
| Total composite income of parent company owners | -18.52%-72.06M | -29.39%-53.21M | -96.48%-16.53M | -744.26%-135.88M | -251.08%-60.81M | -231.03%-41.12M | ---8.41M | -74.38%21.09M | -47.90%40.25M | -49.42%31.38M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Adverse Opinion | -- | -- | -- | Adverse Opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.